Becton, Dickinson and Company BDX Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Segment Other Operating Expense (Income), net as a Percent of Revenues by Business | |||||
| Medical | 0.2%— | 0%+0.1pp | -0.1%— | —— | |
| Revenue, remaining performance obligation, amount by Product | |||||
| Consumables | $8.8B+3.5% | $8.5B+3.7% | $8.2B-6.8% | $8.8B-17.0% | |
| Products and/or Services | $10B+9.9% | $9.1B-7.1% | $9.8B+8.9% | $9B+15.4% | |
| Revenue by Geography | |||||
| EMEA | $4.73B+7.4% | $4.4B+3.7% | $4.24B+5.0% | $4.04B-11.1% | |
| Greater Asia | $3.09B+6.4% | $2.91B-0.2% | $2.91B-4.4% | $3.05B-0.7% | |
| International | $8.59B+0.9% | $8.51B+3.1% | $8.26B+1.4% | $8.15B-9.6% | |
| Other | $1.23B+1.7% | $1.21B+9.5% | $1.1B+4.2% | $1.06B-7.4% | |
| UNITED STATES | $12.46B+6.8% | $11.66B+4.9% | $11.11B+3.6% | $10.72B+0.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Becton, Dickinson and Company break its business down?
- Becton, Dickinson and Company (BDX) reports segment other operating expense (income), net as a percent of revenues by business across 5 parts — BioPharma Systems, Connected Care, Interventional, Medical Essentials and Medical. Each is extracted from the segment footnotes and tracked over time.
- Where does Becton, Dickinson and Company's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Becton, Dickinson and Company's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
